Tumor necrosis factor-308 polymorphism increases the embryo implantation rate in women undergoing in vitro fertilization

Human Reproduction

Volumn 28, Issue 10, 2013, Pages 2774-2783

  Vialard, F ^a,b,c   El Sirkasi, M ^a   Tronchon, V ^a   Boudjenah, R ^c   Molina Gomes, D ^b,c   Bergere, M ^b,c   Mauduit, C ^a,d,e,f   Wainer, R ^b,c   Selva, J ^b,c   Benahmed, M ^a,d,g  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e UNIVERSITÉ LYON 1   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

^g INSERM   (France)

Author keywords

eSET; implantation; polymorphism; predictive biomarker; tumor necrosis factor

Indexed keywords

FOLLITROPIN; RECOMBINANT FOLLITROPIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR 308; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; KARYOTYPE; MAJOR CLINICAL STUDY; MALE FERTILITY; MULTIPLE PREGNANCY; NIDATION; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PREGNANCY RATE; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION;

ESET; IMPLANTATION; POLYMORPHISM; PREDICTIVE BIOMARKER; TUMOR NECROSIS FACTOR;

ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; GENETIC MARKERS; HUMANS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885159867     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det264     Document Type: Article

References (69)

1. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease. J Leukoc Biol 1999;66:562-566.
2. Almog B, Shalom-Paz E, Dufort D, TulandiT. Promoting implantation by local injury to the endometrium. Fertil Steril 2010;94:2026-2029.
3. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80:1908-1915.
4. ASRM. Elective single-embryo transfer. Fertil Steril 2012;97:835-842.
5. Barash A, DekelN, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003;79:1317-1322.
6. Boomsma CM, Kavelaars A, Eijkemans MJ, Lentjes EG, Fauser BC, Heijnen CJ, Macklon NS. Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod 2009; 24:1427-1435.
7. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
8. Chaouat G, Dubanchet S, Ledee N. Cytokines: Important for implantation?. J Assist Reprod Genet 2007;24:491-505.
9. Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V. Twins: Prevalence, problems, and preterm births. Am J Obstet Gynecol 2010; 203:305-315.
10. Check JH, Katsoff B, JamisonT, Choe JK, Brasile D, Amui J. Anovel method to assess the effect of uterine senescence by comparing pregnancy outcome in younger donors vs older recipients who are sharing a common pool of oocytes. Clin Exp Obstet Gynecol 2010;37:97-98.
11. Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN, Yang YS. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril 2003; 79:63-68.
12. Cohen M, Meisser A, Haenggeli L, Bischof P. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 2006;12:225-232.
13. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994;39: 150-154.
14. De Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A. Assisted reproductive technology in Europe, 2006: Results generated from European registers by ESHRE. Hum Reprod 2010;25:1851-1862.
15. De Sutter P, Gerris J, Dhont M. A health-economic decision-analytic model comparing double with single embryo transfer in IVF/ICSI. Hum Reprod 2002;17:2891-2896.
16. Falconer H, Sundqvist J, Gemzell-Danielsson K, von Schoultz B, D'Hooghe TM, Fried G. IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Mullerian hormone. Reprod Biomed Online 2009;18:582-588.
17. Fong CL, Mark DF. The NF-kappa B-like site in the TNF-alpha repressor element is essential for its repressor function. Biochem Biophys Res Commun 1995;212:879-886.
18. George K, Kamath MS. Fertility and age. J Hum Reprod Sci 2010;3:121-123.
19. Giacomucci E, Bulletti C, Polli V, Prefetto RA, Flamigni C. Immunologically mediated abortion (IMA). J Steroid Biochem Mol Biol 1994;49:107-121.
20. Gnainsky Y, Granot I, Aldo PB, Barash A, Or Y, Schechtman E, Mor G, Dekel N. Local injury of the endometrium induces an inflammatory response that promotes successful implantation. Fertil Steril 2010; 94:2030-2036.
21. Haider S, Knofler M. Human tumour necrosis factor: Physiological and pathological roles in placenta and endometrium. Placenta 2009; 30:111-123.
22. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001;62:1191-1199.
23. Haouzi D, Assou S, Mahmoud K, Tondeur S, Reme T, Hedon B, De Vos J, Hamamah S. Gene expression profile of human endometrial receptivity: Comparison between natural and stimulated cycles for the same patients. Hum Reprod 2009;24:1436-1445.
24. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
25. Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 1999;54:138-145.
26. Horcajadas JA, Riesewijk A, Martin J, Cervero A, Mosselman S, Pellicer A, Simon C. Global gene expression profiling of human endometrial receptivity. J Reprod Immunol 2004;63:41-49.
27. Horcajadas JA, Minguez P, Dopazo J, Esteban FJ, Dominguez F, Giudice LC, Pellicer A, Simon C. Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab 2008;93:4500-4510.
28. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997; 72:149-153.
29. Jungheim ES, Ryan GL, Levens ED, Cunningham AF, Macones GA, Carson KR, Beltsos AN, Odem RR. Embryo transfer practices in the United States: A survey of clinics registered with the Society for Assisted Reproductive Technology. Fertil Steril 2010;94:1432-1436.
30. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000; 114:1180-1183.
31. Kowalczyk AE, Kaczmarek MM, Schams D, Ziecik AJ. Effect of prostaglandin E2 and tumor necrosis factor alpha on the VEGF-receptor system expression in cultured porcine luteal cells. Mol Reprod Dev 2008; 75:1558-1566.
32. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-130.
33. Li R, Hao G. Local injury to the endometrium: Its effect on implantation. Curr Opin Obstet Gynecol 2009;21:236-239.
34. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006; 27:170-207.
35. Maheshwari A, Griffiths S, Bhattacharya S. Global variations in the uptake of single embryo transfer. Hum Reprod Update 2011;17:107-120.
36. Martin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V. Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 1996;65:1238-1240.
37. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol Genet Metab 2005;86:293-299.
38. Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999;5:252-260.
39. Nadif R, Jedlicka A, Mintz M, Bertrand JP, Kleeberger S, Kauffmann F. Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: A model of gene-environment interaction. Tumour necrosis factor and lymphotoxin alpha. J Med Genet 2003;40:96-103.
40. Nedoszytko B, Szczerkowska-Dobosz A, Zablotna M, Glen J, Rebala K, Roszkiewicz J. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 2007;157:165-167.
41. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, Goeddel DV, Gray PW. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucleic Acids Res 1985;13:6361-6373.
42. O'Connor KA, Holman DJ, Wood JW. Declining fecundity and ovarian ageing in natural fertility populations. Maturitas 1998;30:127-136.
43. Pandian Z, Bhattacharya S, Ozturk O, Serour G, Templeton A. Number of embryos for transfer following in-vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev 2009:CD003416.
44. Payan-Carreira R, Pires MA, Strom Holst B, Rodriguez-Martinez H. Tumour necrosis factor in the canine endometrium: An immunohistochemical study. Reprod Domest Anim 2011;46:410-418.
45. Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: Influence of women's age on pregnancy rates. Hum Reprod 1990;5:56-59.
46. Pinborg A. IVF/ICSI twin pregnancies: Risks and prevention. Hum Reprod Update 2005;11:575-593.
47. Roberts JE, Spandorfer S, Fasouliotis SJ, Kashyap S, Rosenwaks Z. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization. Fertil Steril 2005;83:37-41.
48. Rodriguez-Murillo L, Greenberg DA. Genetic association analysis: A primer on how it works, its strengths and its weaknesses. Int J Androl 2008; 31:546-556.
49. Rosario GX, Sachdeva G, Manjramkar DD, Puri CP. Enhanced expressions of endometrial tumour necrosis factor alpha and its receptors during early pregnancy in bonnet monkeys. Cytokine 2005;31:459-464.
50. Sakumoto R, ShibayaM, Okuda K. Tumor necrosis factor-alpha (TNF alpha) inhibits progesterone and estradiol-17beta production from cultured granulosa cells: Presence of TNFalpha receptors in bovine granulosa and theca cells. J Reprod Dev 2003;49:441-449.
51. Salama SA, Kamel MW, Diaz-Arrastia CR, Xu X, Veenstra TD, Salih S, Botting SK, Kumar R. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: Potential physiological and pathological relevance. J Clin Endocrinol Metab 2009;94:285-293.
52. Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigiani M, Sbracia M. Natural-cycle in vitro fertilization in poor responder patients: A survey of 500 consecutive cycles. Fertil Steril 2009; 92:1297-1301.
53. Semer D, Reisler K, MacDonald PC, Casey ML. Responsiveness of human endometrial stromal cells to cytokines. Ann N Y Acad Sci 1991; 622:99-110.
54. Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, Chou MC, Lin LY. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 2006;52:15-20.
55. Sifer C, Sermondade N, Poncelet C, Hafhouf E, Porcher R, Cedrin-Durnerin I, Benzacken B, Levy R, Hugues JN. Biological predictive criteria for clinical pregnancy after elective single embryo transfer. Fertil Steril 2010;95:427-430.
56. Simoni M, Nieschlag E, Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: Implications for human reproduction. Hum Reprod Update 2002;8:413-421.
57. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004;2:59.
58. Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG. The cumulative embryo score: A predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1992;7:117-119.
59. Tabibzadeh S, Satyaswaroop PG, von Wolff M, Strowitzki T. Regulation of TNF-alpha mRNA expression in endometrial cells by TNF-alpha and by oestrogen withdrawal. Mol Hum Reprod 1999;5:1141-1149.
60. Thathiah A, Brayman M, Dharmaraj N, Julian JJ, Lagow EL, Carson DD. Tumor necrosis factor alpha stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology 2004;145:4192-4203.
61. Toder V, Fein A, Carp H, Torchinsky A. TNF-alpha in pregnancy loss and embryo maldevelopment: A mediator of detrimental stimuli or a protector of the fetoplacental unit?. J Assist Reprod Genet 2003; 20:73-81.
62. Tronchon V, Vialard F, El Sirkasi M, Dechaud H, Rollet J, Albert M, Bailly M, Roy P, Mauduit C, Fenichel P et al. Tumor necrosis factor-alpha -308 polymorphism in infertile men with altered sperm production or motility. Hum Reprod 2008;23:2858-2866.
63. van Montfoort AP, Fiddelers AA, Janssen JM, Derhaag JG, Dirksen CD, Dunselman GA, Land JA, Geraedts JP, Evers JL, Dumoulin JC. In unselected patients, elective single embryo transfer prevents all multiples, but results in significantly lower pregnancy rates compared with double embryo transfer: A randomized controlled trial. Hum Reprod 2006;21:338-343.
64. van Mourik MS, Macklon NS, Heijnen CJ. Embryonic implantation: Cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol 2009;85:4-19.
65. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91:3574-3581.
66. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?. Immunol Today 1993;14:353-356.
67. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:3195-3199.
68. Yucesoy B, Vallyathan V, Landsittel DP, Simeonova P, Luster MI. Cytokine polymorphisms in silicosis and other pneumoconioses. Mol Cell Biochem 2002;234-235:219-224.
69. Zhu KY, Clark JM. Addition of a competitive primer can dramatically improve the specificity of PCR amplification of specific alleles. Biotechniques 1996; 21:586, 590.